MEDICO REMEDIES LIMITED (MEDICO) financials

MEDICO REMEDIES LIMITED (MEDICO) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Incorporated in 1994, Medico Remedies Ltd manufactures and sells pharmaceutical formulations[1]

Market Cap: ₹170Cr.
Current Price: ₹20.5
Stock P/E: 12.3
ROE: 19.0%
ROCE: 23.3%
Book Value: ₹9.10
Dividend Yield: 0.00%
52W High / Low: ₹57.0/20.3

In Jun 2026, MEDICO REMEDIES LIMITED (MEDICO) reported sales ₹69.40 Cr and net profit ₹2.52 Cr.

Annual TTM: sales ₹238 Cr, net profit ₹14 Cr.

Shareholding: Promoters 61.38% (Sep 2026), FIIs 0.60% (Sep 2026), DIIs 0.00% (Sep 2026), Public 38.02% (Sep 2026), No. of Shareholders 17,716% (Sep 2026).

MEDICO quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	39.35	39.49	41.30	38.25	52.64	58.68	56.81	69.40
Expenses	36.94	36.38	34.64	35.43	49.91	54.35	49.66	66.10
Operating Profit	2.41	3.11	6.66	2.82	2.73	4.33	7.15	3.30
OPM %	6.12%	7.88%	16.13%	7.37%	5.19%	7.38%	12.59%	4.76%
Other Income	0.68	1.43	0.29	0.66	1.72	0.68	2.87	1.17
Interest	0.21	0.28	0.49	0.28	0.24	0.39	0.90	0.41
Depreciation	0.75	0.76	0.77	0.77	0.73	0.79	0.80	0.72
Profit before tax	2.13	3.50	5.69	2.43	3.48	3.83	8.32	3.34
Tax %	27.23%	25.14%	23.90%	25.51%	25.86%	25.07%	29.69%	24.55%
Net Profit	1.55	2.62	4.34	1.82	2.57	2.87	5.86	2.52
EPS in Rs	0.19	0.32	0.52	0.22	0.31	0.35	0.71	0.30
Raw PDF	—	—	—	—	—	—	—	—

MEDICO profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	89	122	121	140	145	151	206	238
Expenses	86	117	114	131	132	136	189	220
Operating Profit	3	5	7	10	13	15	17	18
OPM %	3.2%	4.3%	6%	7%	9%	10%	8%	7%
Other Income	2	1	2	4	2	3	6	6
Interest	1	1	1	1	1	1	2	2
Depreciation	2	2	2	3	3	3	3	3
Profit before tax	2	4	6	10	11	14	18	19
Tax %	26%	30%	26%	28%	27%	25%	27%	—
Net Profit	2	3	5	7	8	10	13	14
EPS in Rs	0.20	0.31	0.58	0.87	1.00	1.22	1.58	1.67
Dividend Payout %	0%	0%	0%	0%	0%	0%	0%	—

MEDICO balance sheet (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	4	4	4	17	17	17	17	17
Reserves	24	26	28	20	27	36	46	59
Borrowings	14	14	15	13	10	8	14	19
Other Liabilities	35	32	28	28	34	36	43	59
Total Liabilities	76	75	76	77	87	96	120	153
Fixed Assets	12	13	15	18	22	21	21	20
CWIP	1	2	0	0	0	0	0	3
Investments	0	0	1	0	1	2	2	2
Other Assets	63	60	59	59	64	73	96	129
Total Assets	76	75	76	77	87	96	120	153

MEDICO cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	5	1	-11	6	8	2	5	6
Cash from Investing Activity	-4	-3	-17	-2	-7	-3	-3	-5
Cash from Financing Activity	-1	3	18	-6	-2	-0	-1	-1
Net Cash Flow	-0	0	-10	-2	-0	-1	1	1
Free Cash Flow	1	-2	-28	3	2	-0	2	1
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	198%	53%	-198%	104%	111%	43%	58%	64%

MEDICO shareholding pattern (%)
Category	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Promoters	66.83%	63.79%	62.59%	61.38%	61.38%	61.38%	61.38%	61.38%
FIIs	0.39%	0.11%	0.07%	0.30%	0.49%	0.03%	0.08%	0.60%
DIIs	0.78%	0.01%	0.01%	0.01%	0.00%	0.00%	0.00%	0.00%
Public	32.00%	36.08%	37.33%	38.30%	38.13%	38.60%	38.55%	38.02%
No. of Shareholders	14,104	15,424	16,474	18,503	16,562	16,189	15,863	17,716

MEDICO key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	109	98	82	92	94	125	138	145
Inventory Days	74	99	58	76	69	54	90	72
Days Payable	149	143	100	113	108	105	117	119
Cash Conversion Cycle	33	54	39	54	54	75	111	98
Working Capital Days	49	61	50	52	54	74	90	84
ROCE %	8%	8%	10%	15%	21%	21%	21%	23%

MEDICOUpdated 23 Oct 2026, 2:03

Medico Remedies Limited

MEDICOUpdated 23 Oct 2026, 2:03

Market Cap

₹170Cr.

Current Price

₹20.5

High / Low

₹57.0/20.3

Stock P/E

12.3

Book Value₹9.10

Dividend Yield0.00%

ROCE23.3%

ROE19.0%

Face Value₹2.00

About

Incorporated in 1994, Medico Remedies Ltd manufactures and sells pharmaceutical formulations[1]

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2023	31.47	0.17	29.01	0.31	0.71	1.89	29.63	1.32	0.16
Sep 2023	42.36	0.18	39.29	0.96	0.71	3.14	22.61	2.43	0.29
Dec 2023	29.77	0.22	27.04	0.27	0.72	2.06	30.1	1.45	0.17
Mar 2024	41.32	0.25	36.67	0.58	0.74	4.24	26.89	3.1	0.37
Jun 2024	30.8	0.18	27.98	0.29	0.75	2.18	27.06	1.58	0.19
Sep 2024	39.35	0.21	36.94	0.68	0.75	2.13	27.23	1.55	0.19
Dec 2024	39.49	0.28	36.38	1.43	0.76	3.5	25.14	2.62	0.32
Mar 2025	41.3	0.49	34.64	0.29	0.77	5.69	23.9	4.34	0.52
Jun 2025	38.25	0.28	35.43	0.66	0.77	2.43	25.51	1.82	0.22
Sep 2025	52.64	0.24	49.91	1.72	0.73	3.48	25.86	2.57	0.31
Dec 2025	58.68	0.39	54.35	0.68	0.79	3.83	25.07	2.87	0.35
Mar 2026	56.81	0.9	49.66	2.87	0.8	8.32	29.69	5.86	0.71
Jun 2026	69.4	0.41	66.1	1.17	0.72	3.34	24.55	2.52	0.3

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2015	51	1	48	0	1	1	28	1	0.12
Mar 2016	67	1	63	0	1	2	40	1	0.18
Mar 2017	54	1	50	0	1	2	4	2	0.25
Mar 2018	61	2	58	1	1	2	35	1	0.15
Mar 2019	98	1	95	2	2	2	28	2	0.19
Mar 2020	89	1	86	2	2	2	26	2	0.2
Mar 2021	122	1	117	1	2	4	30	3	0.31
Mar 2022	121	1	114	2	2	6	26	5	0.58
Mar 2023	140	1	131	4	3	10	28	7	0.87
Mar 2024	145	1	132	2	3	11	27	8	1
Mar 2025	151	1	136	3	3	14	25	10	1.22
Mar 2026	206	2	189	6	3	18	27	13	1.58
TTM	238	2	220	6	3	19	—	14	1.67

Shareholding pattern

As of Sep 2026%

Holder	Share
Promoters	61.38%
FIIs	0.6%
Public	38.02%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Public
Dec 2023	73.34%	1.29%	0%	25.36%
Mar 2024	73.34%	0.29%	0.74%	25.63%
Jun 2024	73.34%	0.22%	0.97%	25.46%
Sep 2024	73.34%	0.22%	0.97%	25.47%
Dec 2024	66.83%	0.39%	0.78%	32%
Mar 2025	63.79%	0.11%	0.01%	36.08%
Jun 2025	62.59%	0.07%	0.01%	37.33%
Sep 2025	61.38%	0.3%	0.01%	38.3%
Dec 2025	61.38%	0.49%	0%	38.13%
Mar 2026	61.38%	0.03%	0%	38.6%
Jun 2026	61.38%	0.08%	0%	38.55%
Sep 2026	61.38%	0.6%	0%	38.02%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Mar 2015	2	12	8	14	36	8	0	1	27	36
Mar 2016	2	13	14	17	46	7	0	1	38	46
Mar 2017	3	13	19	13	48	7	3	0	39	48
Mar 2018	4	23	13	20	59	7	4	0	48	59
Mar 2019	4	24	14	35	76	12	1	0	63	76
Mar 2020	4	26	14	32	75	13	2	0	60	75
Mar 2021	4	28	15	28	76	15	0	1	59	76
Mar 2022	17	20	13	28	77	18	0	0	59	77
Mar 2023	17	27	10	34	87	22	0	1	64	87
Mar 2024	17	36	8	36	96	21	0	2	73	96
Mar 2025	17	46	14	43	120	21	0	2	96	120
Mar 2026	17	59	19	59	153	20	3	2	129	153

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2015	—	—	—	—
Mar 2016	—	—	—	—
Mar 2017	-3	-3	6	0
Mar 2018	5	-5	-1	0
Mar 2019	5	-4	-1	0
Mar 2020	1	-3	3	0
Mar 2021	-11	-17	18	-10
Mar 2022	6	-2	-6	-2
Mar 2023	8	-7	-2	0
Mar 2024	2	-3	0	-1
Mar 2025	5	-3	-1	1
Mar 2026	6	-5	-1	1

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	53	107	122	102	109	98	82	92	94	125	138	145
Inventory Days	76	63	96	125	74	99	58	76	69	54	90	72
Days Payable	122	106	112	147	149	143	100	113	108	105	117	119
Cash Conversion Cycle	6	64	105	80	33	54	39	54	54	75	111	98
Working Capital Days	21	53	110	88	49	61	50	52	54	74	90	84
ROCE %	10%	11%	10%	9%	8%	8%	10%	15%	21%	21%	21%	23%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of MEDICO REMEDIES LIMITED (MEDICO)?

The reported market capitalisation for MEDICO REMEDIES LIMITED (MEDICO) is ₹170Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of MEDICO?

The current price shown for MEDICO REMEDIES LIMITED (MEDICO) on Fincrux is ₹20.5 with a 52-week high/low of ₹57.0/20.3.

What is the P/E ratio of MEDICO REMEDIES LIMITED (MEDICO)?

The stock P/E for MEDICO REMEDIES LIMITED (MEDICO) is 12.3 on Fincrux, with ROE at 19.0% and ROCE at 23.3%.

What were MEDICO latest quarterly results?

For Jun 2026, MEDICO REMEDIES LIMITED (MEDICO) reported sales ₹69.40 Cr and net profit ₹2.52 Cr (figures in ₹ crore unless noted).

What are MEDICO annual sales and net profit?

For TTM, MEDICO REMEDIES LIMITED (MEDICO) shows sales of ₹238 Cr and net profit of ₹14 Cr on the Fincrux profit & loss statement.

Who owns MEDICO REMEDIES LIMITED (MEDICO)?

Latest shareholding for MEDICO REMEDIES LIMITED (MEDICO) on Fincrux: Promoters 61.38% (Sep 2026), FIIs 0.60% (Sep 2026), DIIs 0.00% (Sep 2026), Public 38.02% (Sep 2026), No. of Shareholders 17,716% (Sep 2026).

Where can I find MEDICO REMEDIES LIMITED (MEDICO) financials?

MEDICO REMEDIES LIMITED (MEDICO) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show MEDICO balance sheet and cash flow?

Yes. The MEDICO REMEDIES LIMITED (MEDICO) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 23 October 2026 at 2:03